Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 982-989

  Lkhagva, Baigalmaa ^a   Chang, Shih Lin ^b   Chen, Yao Chang ^c   Kao, Yu Hsun ^a,d   Lin, Yung Kuo ^d   Chiu, Cindy Tzu Hsuan ^e   Chen, Shih Ann ^b   Chen, Yi Jen ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Atrial fibrillation; Calcium homeostasis; Histone deacetylase inhibition; Pulmonary vein

Indexed keywords

3 (1 BENZENESULFONYL 1H INDOL 5 YL) N HYDROXYACRYLAMIDE; CALCIUM; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME INHIBITION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY VEIN; RABBIT; SODIUM CURRENT; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP;

EID: 84920026023     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.175     Document Type: Article

References (35)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart disease and stroke statistics-2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. D Dobrev, L. Carlsson, and S. Nattel Novel molecular targets for atrial fibrillation therapy Nat Rev Drug Discov 11 2012 275 291
3. D Dobrev, and S. Nattel New antiarrhythmic drugs for treatment of atrial fibrillation Lancet 375 2010 1212 1223
4. T.A. McKinsey Therapeutic potential for HDAC inhibitors in the heart Annu Rev Pharmacol Toxicol 52 2012 303 319
5. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32 42
6. Y.H. Kao, J.P. Liou, C.C. Chung, G.S. Lien, C.C. Kuo, and S.A. Chen Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure Int J Cardiol 168 2013 4178 4183
7. T.A. McKinsey Targeting inflammation in heart failure with histone deacetylase inhibitors Mol Med 17 2011 434 441
8. H. Tao, K.H. Shi, J.J. Yang, C. Huang, H.Y. Zhan, and J. Li Histone deacetylases in cardiac fibrosis: Current perspectives for therapy Cell Signal 26 2013 521 527
9. F. Liu, M.D. Levin, N.B. Petrenko, M.M. Lu, T. Wang, and L.J. Yuan Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin J Mol Cell Cardiol 45 2008 715 723
10. D. Zhang, C.T. Wu, X. Qi, R.A. Meijering, F. Hoogstra-Berends, and A. Tadevosyan Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment of alpha-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation Circulation 129 2014 346 358
11. Y.J. Chen, and S.A. Chen Electrophysiology of Pulmonary Veins J Cardiovasc Electrophysiol 17 2006 220 224
12. S. Nattel Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms Can J Cardiol 29 2013 1147 1149
13. S.H. Chang, Y.C. Chen, S.J. Chiang, S. Higa, C.C. Cheng, and Y.J. Chen Increased Ca(2 +) sparks and sarcoplasmic reticulum Ca(2 +) stores potentially determine the spontaneous activity of pulmonary vein cardiomyocytes Life Sci 83 2008 284 292
14. R. Wakili, N. Voigt, S. Kaab, D. Dobrev, and S. Nattel Recent advances in the molecular pathophysiology of atrial fibrillation J Clin Invest 121 2011 2955 2968
15. N Voigt, N Li, Q Wang, W. Wang, A.W. Trafford, and I. Abu-Taha Enhanced Sarcoplasmic Reticulum Ca2 + Leak and Increased Na + -Ca2 + Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation Circulation 125 2012 2059 2070
16. S.L. Chang, Y.C. Chen, C.P. Hsu, Y.H. Kao, Y.K. Lin, and Y.J. Lai Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart Int J Cardiol 168 2013 4019 4026
17. Y.J. Chen, Y.C. Chen, W. Wongcharoen, C.I. Lin, and S.A. Chen Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes Br J Pharmacol 153 2008 915 925
18. Y.J. Chen, S.A. Chen, M.S. Chang, and C.I. Lin Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation Cardiovasc Res 48 2000 265 273
19. R.I. Birchfield, E.E. Menefee, and G.D. Bryant Disease of the sinoatrial node associated with bradycardia, asystole, syncope, and paroxysmal atrial fibrillation Circulation 16 1957 20 26
20. TA. McKinsey, C.L. Zhang, and E.N. Olson MEF2 a calcium-dependent regulator of cell division, differentiation and death Trends Biochem Sci 27 2002 40 47
21. S. Chandrasekaran, R.E. Peterson, S.K. Mani, B. Addy, A.L. Buchholz, and L. Xu Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes FASEB J 23 2009 3851 3864
22. Y.C. Chen, S.A. Chen, Y.J. Chen, C.T. Tai, P. Chan, and C.I. Lin T-type calcium current in electrical activity of cardiomyocytes isolated from rabbit pulmonary vein J Cardiovasc Electrophysiol 15 2004 567 571
23. E. Hu, E. Dul, C.M. Sung, Z. Chen, R. Kirkpatrick, and G.F. Zhang Identification of novel isoform-selective inhibitors within class I histone deacetylases J Pharmacol Exp Ther 307 2003 720 728
24. A. Mai, S. Massa, R. Pezzi, S. Simeoni, D. Rotili, and A. Nebbioso Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides J Med Chem 48 2005 3344 3353
25. S.L. Chang, Y.C. Chen, Y.H. Yeh, Y.K. Lin, T.J. Lin, and C.L. Lin Heart failure enhanced pulmonary vein arrhythmogenesis and dysregulated sodium and calcium homeostasis with increased calcium sparks J Cardiovasc Electrophysiol 22 2011 1378 1386
26. S.L. Chang, Y.C. Chen, C.P. Hsu, Y.H. Kao, Y.K. Lin, and Y.J. Lin Electrophysiological characteristics of complex fractionated electrograms and high frequency activity in atrial fibrillation Int J Cardiol 168 2013 2289 2299
27. N. Voigt, J. Heijman, Q. Wang, D.Y. Chiang, N. Li, and M. Karck Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation Circulation 129 2014 145 156
28. Y.C. Chen, Y.Y. Lu, C.C. Cheng, Y.K. Lin, S.A. Chen, and Y.J. Chen Sinoatrial node electrical activity modulates pulmonary vein arrhythmogenesis Int J Cardiol 15 2014 [00434-00433]
29. S.L. Chang, Y.C. Chen, Y.H. Yeh, Y.J. Lai, H.I. Yeh, and C.L. Lin Heart failure enhances arrhythmogenesis in pulmonary veins Clin Exp Pharmacol Physiol 38 2011 666 674
30. A. Pedram, M. Razandi, R. Narayanan, J.T. Dalton, T.A. McKinsey, and E.R. Levin Estrogen regulates histone deacetylases to prevent cardiac hypertrophy Mol Biol Cell 24 2013 3805 3818
31. L. Yang, M. Qu, Y. Wang, H. Duan, P. Chen, and Y. Wang Trichostatin A inhibits transforming growth factor-beta-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling Mol Pharmacol 83 2013 671 680
32. J.P. Cardinale, S. Sriramula, R. Pariaut, A. Guggilam, N. Mariappan, and C.M. Elks HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats Hypertension 56 2010 437 444
33. S.M. Williams, L. Golden-Mason, B.S. Ferguson, K.B. Schuetze, M.A. Cavasin, and K. Demos-Davies Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes J Mol Cell Cardiol 67 2014 112 125
34. I. Savelieva, N. Kakouros, A. Kourliouros, and A.J. Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention Europace 13 2011 308 328
35. Y.M. Lu, J. Huang, N. Shioda, K. Fukunaga, Y. Shirasaki, and X.M. Li CaMKIIdeltaB mediates aberrant NCX1 expression and the imbalance of NCX1/SERCA in transverse aortic constriction-induced failing heart PLoS One 6 2011 e24724